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Invasion and tumor cellFormation of metastases negatively impacts the survival prognosis of cancer patients. Globally, if the
various steps involved in their formation are relatively well identiﬁed, the molecular mechanisms
responsible for the emergence of invasive cancer cells are still incompletely resolved. Elucidating
what are the mechanisms that allow cancer cells to evade from the tumor is a crucial point since
it is the ﬁrst step of the metastatic potential of a solid tumor. In order to be invasive, cancer cells
have to undergo transformations such as down-regulation of cell-cell adhesions, modiﬁcation of
cell-matrix adhesions and acquisition of proteolytic properties. These transformations are accompa-
nied by the capacity to ‘‘activate’’ stromal cells, which may favor the motility of the invasive cells
through the extracellular matrix. Since modulation of gap junctional intercellular communication
is known to be involved in cancer, we were interested to consider whether these different transfor-
mations necessary for the acquisition of invasive phenotype are related with gap junctions and their
structural proteins, the connexins. In this review, emerging roles of connexins and gap junctions in
the process of tissue invasion are proposed.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Formation and growth of secondary tumors (metastases) in vi-
tal organs negatively impact the survival prognosis of cancer pa-
tients. Since more than 90% of deaths by solid tumors are the
consequence of metastatic growth, it is crucial to decipher molec-
ular mechanisms responsible for such a process in order to dis-
cover potential therapeutic targets that could prevent its
development [1].
Globally, the various steps involved in the formation of metas-
tases from the spreading of invasive cells coming out from the
primitive tumor are relatively well identiﬁed and individualized.
Covering the distance from the primary tumor to the ﬁnal location
of metastases involves the crossing of several physical barriers by
the invading tumor cells. This means that these cells are not only
able to migrate through the extracellular matrix around the tumor
but have afterwards to cross the endothelial barriers of the blood
or lymphatic vessels (intravasation) before reaching distant organs
they may ‘‘colonize’’ after crossing for a second time the endothe-
lial barrier (extravasation). Moreover, during their transportationin the blood circulation, these cancer cells have to resist to
particular mechanical stress (blood stream and pressure) and to
leucocytes that diminishe their survival.
This cascade of events obviously depends on the ﬁrst step which
initiates the apparition of particular subpopulations of cells inside
the primary tumor that acquired molecular criteria required for
spreading out of the core of the tumor. Interestingly, even if this
step controls so-called late stages of tumor progression which
are the apparition of metastases, it becomes obvious that these
invasive capacities are mostly acquired at the beginning of the car-
cinogenesis process and possibly even before the tumor is clinically
diagnosed. Indeed, clinical cases have been described in which
metastases appeared before the primary tumor was diagnosed.
This emphasizes the importance of deciphering the molecular
mechanisms controlling the acquisition of motility and invasive-
ness by some cancer cells even if it does not predict that metasta-
ses will occur because the accomplishment of the following steps
(crossing of endothelial barriers; survival to blood circulation and
mechanical stress) is random.
The apparition of cancer cells able to spread out of the tumor is
thus the very fundamental and initiation step that predetermines
the burden of metastasis formation. Such an initial process mostly
depends on the sequence of the following events which permits to
themalignant cells (1) to loose, through epithelial-to-mesenchymal
transition (EMT), their initial intercellular adhesion to be separated
from the primary tumor, and then, (2) by the secretion of proteases,
to degrade the basal lamina proteins permitting them to migrate
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underneath.
Among this sequence, two major events involve the modulation
of cellular interactions. The ﬁrst one is the physical detachment of
those particular cells from their counterparts in the solid tumor
and then the establishment of cooperative interactions between
these subpopulations of cells and the tissue microenvironment
that permits their migration out of the core of the tumor and the
invasion of the surrounding stroma [2]. Therefore, interactions
playing an important role, most of studies focused for many years
on the implication of cell–cell recognition molecules (cadherins) or
on molecules controlling cell–matrix interactions (integrins). In
parallel, gap junction proteins (connexins) have also been shown
to be involved in non-pathological migration processes such as
those occurring during development: migration of neuron precur-
sors to the cortex [3] or neural crest migration [4]. More recently,
the role of connexins in migration was extended to cancer, during
the past years, data showing that connexins could control migra-
tion and invasion of cancer cells accumulated. Therefore, in order
to understand better what is the real involvement of connexins
and gap junctions in the invasive process, we will review their
implications in the control of adhesion, proteolysis and motility
which govern the spreading of cancer cells.
2. Adhesion
The integrity of tissues and organs is maintained through two
major types of interactions: direct adhesions between cells them-
selves and with the components of the ECM. For carcinoma cells
that initially present an epithelial phenotype, the process of tissue
invasion is mostly the consequence of a loss of intercellular adhe-
sions (cadherins) which is accompanied by a decreased basolateral
polarization and remodeling of cell–ECM adhesions (integrins).
These adhesions are permitted by a chain of protein interactions
(trans-membrane proteins, cytoplasmic molecules and cytoskele-
tal components) joining components of the cytoskeleton to the
extracellular environment such as neighboring cells or ECM [5].
Underneath the plasma membrane, the link with the cytoskeleton
is constituted by multiprotein complexes which anchor to the
transmembrane proteins (cadherins for intercellular adhesion or
integrins for cell–ECM adhesion). Concentration of these ‘‘links’’
in particular spots or regions of the cell constitutes adherens
junctions (intercellular adhesion) or focal adhesion complexes
(cell–ECM adhesion) whose stability depends a lot on the appropri-
ate functionality of the transmembrane ‘‘link’’ which are cadherins
or integrins depending on the adhesion type which is considered.
2.1. Cadherins
Cadherins are particularly known to play a pro- or anti-meta-
static role during this initial phase of adhesion loss between tumor
cells. They are transmembrane glycoproteins responsible for cal-
cium-dependent homophilic adhesion between cells and belong
to a multigene family whose members are differently expressed
depending on the cell type.
Among them, E-cadherin is a fundamental component of adher-
ens junctions between epithelial cells. In cancer, E-cadherin has
been seen for long as an inhibitor of invasion and metastatic poten-
tials of carcinomas. Its role was studied particularly in colon and
breast cancers where invasiveness is inversely correlated with its
level of expression [6–9]. It is important to note that the role of
E-cadherin is not only for maintaining intercellular adhesions.
Indeed, its intra-cytoplasmic interactions with p120-, a-, b- and
c-catenins form a protein complex responsible for a particular
organization of the cytoskeleton that controls the cell shape, polar-
ization and the adhesion of the cells with their neighbors. Anymodiﬁcation of these protein interactions, through Wnt/APC sig-
naling may be the starting point of an intracellular signal affecting
the actin organization necessary for cell migration. Considering
this aspect, it has been suggested that the inhibition of cell migra-
tion by expression of E-cadherin may be mainly due to its capacity
to mediate intracellular signaling rather than the direct formation
of intercellular junctions [10,11]. EMT is a necessary starting point
for local invasion of carcinoma cells. The acquisition of the mesen-
chymal phenotype is accompanied by a switch of cadherin expres-
sion; E-cadherin expression decreases while the amount of another
type (originally, neural type), N-cadherin, increases. Interestingly,
in carcinomas, N-cadherin seems to have an opposite role to E-cad-
herin since its presence is not only associated with the apparition
of mesenchymal characteristics but also to an increased cell migra-
tion capacity [12].
In epithelia, gap junctions are common at the proximity of
intercellular adhesions where they mediate gap junctional inter-
cellular communication (GJIC) which permits the direct transfer
of ions and small metabolites between cytoplasms of neighboring
cells. GJIC decrease and alteration of expression of the structural
proteins of gap junctions, the connexins, have been frequently ob-
served in tumor cells. In various cell types, it has been shown for
many years, that the assembly of connexins in gap junctions
depends on the establishment of adherens junctions mediated by
E-cadherin [13–17].
So, in the context of EMT occurring during carcinoma progres-
sion, it would be interesting to estimate what are the conse-
quences of cadherin switch in the control of gap junction
assembly and mediation of GJIC. Recently a possible link between
GJIC, connexins and cadherin was observed by considering rat li-
ver epithelial cells undergoing EMT. As expected, the N-cadherin/
E-cadherin switch increases the migration/invasion capacity of
those cells but also modulates differently gap junction and GJIC.
Before EMT, E-cadherin expression is associated with the pres-
ence of functional gap junctions. After EMT induction, the in-
crease of N-cadherin prevents the formation of functional gap
junctions. This process seems to prevent the formation of gap
junction plaques (detergent-resistant gap junctions) by inducing
the endocytosis of the responsible connexin, connexin43 (Cx43)
via a non-clathrin-dependent pathway. However, whatever is
the expression of E-cadherin or N-cadherin, the total amount of
Cx43 in the plasma membrane is constant except in the deter-
gent-resistant fractions [18]. Such an observation is in accor-
dance with a previous one showing that functional gap
junctions correspond to detergent-resistant (triton-insoluble frac-
tions) gap junctions. Moreover, these functional gap junctions,
which are known to be localized in lipid rafts, depend on the
phosphorylated status of Cx43 since only the phosphorylated
forms of Cx43 were shown to be targeted to the plasma mem-
brane of the cells [19].
However, from these data, it is premature to conclude that N-
cadherin expression negatively controls gap junction assembly
and function. The story may be more complex and may depend
on the cell type which is considered. For instance, human lung
carcinoma cells (A549 cells) exhibit some heterogeneity with
mesenchymal (ﬁbroblastoid) and epithelial (epitheloid) pheno-
types. These phenotypes are correlated with different motility
capacities; ﬁbroblastoid cells being characterized by a high
motility capacity contrary to the epitheloid cells. While 65% of
epithelioid cells and 48% of ﬁbroblastoid express N-cadherin,
Cx43 is localized to the membrane and form functional plaques
for most epitheloid cells (>90%) contrary to a small portion of
ﬁbroblastoid cells (31%). Moreover, Cx43 is found to be expressed
in the membrane of all ﬁbrobastoid cells and their migration
capacity appeare to occur independently of the formation of
gap junctions [20].
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The contact between cells and ECM is mainly established
through integrins. These transmembrane molecules are activated
when their extracellular domain is associated with particular
ECM proteins (Fibronectin, vitronectin, collagen, laminin). In
response to the integrin activation, many proteins are recruited
to its cytoplasmic domain to form a complex under the plasma
membrane. This protein complex, called focal adhesion complex
(FAC), allows, on one hand, anchoring of the cell cytoskeleton with
ECM, and on the other hand, a transmembrane signal transmission
from outside to inside the cell and vice versa [21,22].
Very few data have shown a possible correlation between inte-
grins and gap junctions. A study concerning human keratinocytes
established a direct link between integrins and GJIC. In such cells,
the cell–matrix junction via integrin a3b1 increases GJIC capacity
when ECM contains laminin-5. This increase is not an up-regula-
tion of expression of the gap junction protein Cx43 at the mRNA
or protein levels. In fact, the authors showed that when cells are
cultured on laminin-5, the interaction between integrin a3b1 and
laminin-5 increases GJIC by favoring the gap junction assembly
of Cx43 in triton-insoluble fractions, (and thus possibly lipid rafts),
of the plasma membrane. Furthermore, the activity of Rho seems
necessary to increase the laminin-mediated GJIC through integrin
a3b1 [23]. It seems that laminin-5/integrin interactions activate
Rho which modulates gap junction assembly and thus GJIC. This
suggests that cell–matrix interactions are also able to modulate
cell–cell interactions such as GJIC.
In other cellular contexts, a link between another gap junction
protein, Cx26, and integrins or their partners has been described.
For instance, in prostate cancer cells, Cx26 expression is correlated
with migration and invasion by interacting with the focal adhesion
kinase (FAK) [24]. However, in breast cancer cells (MDA-MB-435
cells), Cx26 acts in an oppositeway since its overexpression is corre-
latedwith a decrease inmigration or invasion process. Interestingly,
such a decrease is linked to diminished expression of integrin b1
[25]. These data tend to demonstrate that interactions between
the integrin system and connexinsmay act differently on themigra-
tion capacity of cancer cells. Such a different behavior seems to de-
pendboth on the cell type and the connexin typewhich is expressed.3. Proteolysis
Several reviews mentioned that connexins could be involved in
the dissemination of metastatic cancer cells especially during pro-
cesses such as diapedesis permitting to those cells to enter into
(intravasation) or sort out (extravasation) the blood and/or lym-
phatic capillary networks [26,27]. Here, we will focus on the possi-
ble link existing between connexin expression and the invasion
capacity itself that permits cancer cells to invade the peritumoral
microenvironment and reach the capillary network. It is well
known that tissue invasion is based on the capacity of those cells
to degrade proteins that constitute the ECM. Recently, it became
obvious that such a proteolytic phenomenon is complex and is
accompanied by a variety of molecular processes which seems to
depend on an ‘‘activation’’ of the peritumoral stroma. In this part,
we will review data suggesting that connexins or gap junctions
are involved respectively in the proteolytic capacity of the invasive
cancer cells and in the activation of the peritumoral stroma.
3.1. Proteolytic degradation of the extracellular matrix
In Mammals, proteolytic degradation is performed by proteases
belonging to ﬁve major families (cysteine-, aspartate-, threonine-,
serine- and metallo-proteases). The activity of these proteases,which is closely regulated by their counteracting endogenous
inhibitors, is necessary for non-pathological situations such as
embryonic development or renewal of healthy tissues. They are
also involved in pathological processes such as tumor invasion,
with a particularly implication of some of them like serine- and
metallo-proteases that we will review below as uPA/uPAR/PAI
and MMP/TIMP systems. These enzymatic systems, whose mem-
bers are secreted or located on the extracellular surface of the plas-
ma membrane, participate in the degradation of the ECM during
the cancer cell invasion process through a cascade of reactions
leading to proenzyme activation [28].
3.1.1. uPA/uPAR/PAI system
The uPA/uPAR/PAI system is characterized by the enzyme uro-
kinase (or uPA for ‘‘urokinase-type plasminogen activator’’) which
is a member of the serine protease family. The enzyme uPA is ﬁrst
secreted as a proenzyme, pro-uPA, before being activated by plas-
min. Once activated, it binds to the membrane receptor uPAR and
acts as a positive feedback by converting the inactivated plasmin-
ogen to active plasmin which also degrades, in turn, ﬁbrin and
other ECM components. The activity of uPA is negatively regulated
by plasminogen activator inhibitors (PAI-1 and PAI-2), which are
also its substrates that can be involved in the development of
aggressive tumors. Indeed, high rates of intratumoral uPA and
PAI-1 are associated with a high frequency of metastatic recur-
rence of breast cancer [29].
Data establishing a link between uPA system and connexins are
rare. To our knowledge, such a link was revealed in human renal
carcinoma cells (Caki-1 cells). In these cells, the overexpression
of Cx32 is associated with a decreased expression of uPA, uPAR
and PAI-1. Usually, the expression of these ﬁbrinolytic factors is in-
duced by hypoxic-induced factors (HIF-1a and HIF-2a) modulated
by hypoxic conditions [30]. When Cx32 is overexpressed it blocks
the src-dependent induction of HIF-1a and -2a and, in turn, de-
creases the invasive capacity of the cells.
3.1.2. MMP/TIMP system
Among the eight identiﬁed sub-classes of metalloproteases
(MMPs), three are linked to the plasma membrane (MT-MMPs).
Most of the other ones are secreted as pro-enzymes and are acti-
vated in a synergistic manner: the cleavage of MMP pro-domain
by plasmin initiates a self-activation of MMPs in cascade (for
example: MMP-3 activates pro-MMP-1 and pro-MMP-9). More-
over, despite of this type of activation, expression and activation
of MMPs are regulated by a variety of other external stimuli which
are present in the tumor microenvironment such as cytokines, hor-
mones, growth factors, changes in cell–cell and cell–ECM contacts
[31]. Expression and activity of MMPs are increased in most human
cancers and are generally correlated with tumor local invasiveness
and worse clinical prognosis.
The role of tissue inhibitors of metalloproteases (TIMPs) on the
appearance of metastases is less clear. In somemodels, these inhib-
itors induce a pro-tumor action via the expression of anti-apoptotic
(Bcl-XL) or pro-angiogenic (VEGF) factors [32].
The existence of a link between Cx43 and MMP expressions has
been demonstrated in different types of tumor cells [33–35]. In
most cases, cancer cells expressing high level of Cx43 exhibit an
invasive capacity which is higher than cancer cells expressing less.
Such a difference could result from a modiﬁcation in expression
and/or secretion of MMP-2 and -9 by Cx43. For instance, the inva-
sion capacity of C6 glioma cells expressing Cx43, can be reversed
by a synthetic inhibitor of MMPs, BB-94 [34].
Cx26 seems to have an opposite effect compared to Cx43.
Indeed, it has been shown that Cx26 expression in human hepa-
toma cells (HepG2 cells) induces the expression of E-cadherin
which results in a decrease of MMP-9 expression. Therefore,
Fig. 1. Cancer cell invasion: (A) To acquire their invasion capacities, cancer cells undergo epithelial–mesenchymal transition (EMT) at the periphery of the tumor. The ﬁrst
step of detectable invasion is the degradation of the basal membrane that separates the tumor from the stroma. The invapodia is a matrix degrading structure which is
localized on the ventral surface of invasive cells. It allows the ﬁrst step of matrix degradation. (B) Thereafter, the tumor cells invade the underlying stromal tissue or
extracellular matrix (ECM). During this process, individual tumor cells often use a mesenchymal migration, which is characterized by the formation of protrusions
(lamellipodia, invadopodia or ﬁlopodia) in the front of migration. The pericellular proteolysis allows tumor cells to remodel ECM, supporting an invasive migration which is
dependent on integrin, protease and connexin expression. Even if cancer cells collectively migrate by maintaining their cell–cell contacts, they use a similar process by
remodeling and degrading ECM. Finally, tumor cells can also migrate individually by an amoeboid movement, which is favored by the Rho/ROCK – signaling after
mesenchymal amoeboïd transition (MAT). AMT: Amoeboid mesenchymal transition.
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through matrigel in an in vitro assay [36].
Kalra et al., in 2006, studied three variants of Cx26 expressed in
different clones of a breast cancer cell line (MDA-MB-435 cells).
One clone expressed a GJIC-competent Cx26, another one a
GJIC-incompetent GFP-Cx26 chimera and the third one the Cx26
mutant D66H which is localized in the Golgi apparatus. The three
Cx26 variants were shown to be involved in the reduction of cell
migration by altering the cellular distribution of actin ﬁlaments.
Only the Cx26 mutant localized in the Golgi apparatus did not inhi-
bit the invasion capacity of these cells as tested through matrigel.
The three variants decreased the level of integrin b1 expression,
decreased the activity of MMP-9, and increased the activity of the
MMP-1 inhibitor (TIMP1). In consequence, Cx26 seems to be able
to reverse the tumor phenotype by a GJIC-independent way [25].
3.2. ‘‘Activation’’ of the peritumoral stroma
Reaching the stroma compartment by crossing the basal mem-
brane allows tumor cells to interact with a newmicroenvironment.
This new microenvironment seems to be ‘‘activated’’ by the pres-
ence of the tumor cells, favoring their growth and invasion capac-
ity. The activation is mediated by proteolysis of ECM which
releases a large number of sequestered cytokines and/or growth
factors that play a trophic role and a chemo-attracting function
for the invasive tumor cells [37].
During this invasive phase, establishment of GJIC has been ob-
served between tumor cells and stroma cells [38–40]. This wasmostly demonstrated with glioma cells which were shown to
establish heterocellular GJIC with astrocytes both in vitro and
in vivo. Interestingly, some phenotypic modiﬁcations in astrocytes
resulted from this direct interaction as a reactive process. For in-
stance, the size of the astrocytes signiﬁcantly appears smaller in
the presence of Cx43 expressing C6 rat glioma cells compared to
Cx43 non-expressing C6 cells. Secondly, these astrocytes (as stro-
ma cells) express lower levels of GFAP compared to astrocytes cul-
tured in the presence of Cx43 non-expressing C6 cells. These
phenotypic reactions of astrocytes seem to be the consequence of
the establishment of heterocellular GJIC with the glioma cells
expressing Cx43. Such heterocellular GJIC could contribute to a
higher susceptibility of the surrounding tissue to be invaded by tu-
mor cells [38]. Others have also reported that Cx43 is essential for
the invasive process of glioma cells in brain sections by permitting
the establishment of heterocellular GJIC with the stroma cells [39].
Similarly, the high metastatic potential of prostate cancer cells has
been shown to be associated to Cx43 expression and the establish-
ment of heterocellular GJIC with ﬁbroblasts in co-culture [40]. Acti-
vation of the peritumoral stroma may also change the endogenous
GJIC capacity. Indeed, a decrease in homologous GJIC between hu-
man dermal ﬁbroblasts (stromal cells) is observed after addition of
skin tumor cells (SCL-1 cells) in the culture. Interestingly, this GJIC
reduction between the stromal cells seems to be the consequence
of a calcium effect instead of alteration of Cx43 expression or local-
ization [41]. However, such a reaction of the stromal cells may not
always depend on the establishment of heterocellular GJIC with
tumor cells. For instance, even in lack of direct contact, human
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creased GFAP and MMP-2 expressions, decreased Cx43 expres-
sion). In those conditions, MMP-2 increase is associated to the
decrease of TIMP2 expression. Therefore, even without any contact
with glioma cells, the activation of astrocytes may favor the inva-
sion process of glioma cells [42].
It is interesting to note that the invasive process may be differ-
ently regulated depending on the connexin type which is ex-
pressed in tumor cells. For instance, as mentioned above, Cx32
expression in human metastatic renal cancer cells (Caki-1 cells) re-
sults in a reduction of their invasive capacity through src inactiva-
tion. It seems that src inactivation leads to a decrease in VEGF
production via the abolition of STAT-3 activation. Thus, Cx32
expression in tumor cells prevents them to activate cells by stro-
mal VEGF secretion [43].4. Motility
There are different types of cancer cell migration and they de-
pend on the composition and topography of ECM (Fig. 1). For
example, moving of some cancer cells in particular ECMs may de-
pend on their protease activity while it is not the case for others
[44]. On a plane surface, cell migration appears to be a cyclic pro-
cess exhibiting four different stages. First, the cell is polarized and
produces membrane extensions to its ‘‘front’’. These extensions
(lamellipodia and ﬁlopodia) are stabilized by cell–matrix adhe-
sions or focal adhesions [45]. Thereafter, the cell ‘‘body’’ moves
in the direction of extension, using these anchored points. Finally,
after disassembly of rear cell–matrix adhesions, the cell shrinks
back. These steps are directly dependent on cytoskeletal rearrange-
ments, cell–matrix adhesions and can be regulated by soluble fac-
tors which are secreted in the microenvironment [46].
Here, we will review how these different modes of cell migra-
tion and cytoskeleton rearrangements can be related respectively
to gap junction and connexin expressions.
4.1. Different modes of cell migration/invasion
One type of cell migration is the ‘‘amoeboid’’ migration which is
characterized by a round cell morphology and occurs after an epi-
thelial to amoeboid transition (EAT). This migration is not based on
the existence of focal contacts and cell–matrix interactions appear
limited in this case. This amoeboid migration, or ‘‘pseudo-crawling
amoeboid’’ movement, is characterized by cells changing their
shape in order to ‘‘slide’’ between the collagen ﬁbers of ECM with-
out degrading it. In vitro, tumor cell lines using this type of migra-
tion would be essentially from lymphomatous or carcinomatous
origins (mainly small cell lung carcinomas).
After EMT, carcinoma cells are ‘‘liberated’’ and can move indi-
vidually because of the loss of function of cadherins. These cells
can then perform mesenchymal migration (elongated shape with
ﬁbroblast morphology). This individual ‘‘ﬁbroblastoid’’ migration
is realized by the invasive tumor cell repeating the four following
steps: extension/adhesion/retraction/movement, to which is added
ECM degradation. This degradation, localized in ventral region of
the cell which is embedded in the ECM with many focal contacts,
is associated with proteases (secreted or present on outer surface
of the plasma membrane) expressed at the level of invadopodial
structures. These cellular movements can be studied with different
technics in the laboratory. In most cases, the so-called 2D migra-
tion is mostly observed on plane surfaces by performing a wound
healing assay while the 3D migration or invasion is observed in
Boyden chambers coated or not with a matrix (matrigel or speciﬁc
ECM proteins). This last type of migration can be also tested in
ex vivo organotypic slice invasion assay or in in vivo experiments.Therefore, by using such techniques, it is possible to observe the
various processes used by tumor cells to migrate or invade their
environnment [46–49].
By using techniques testing 2D migration, the motility process
seems to be mostly associated with a reduced expression of
Cx43. Indeed, in a study in which glioma cells, dissected from dif-
ferent regions of a canine brain tumor, were placed in a culture
dish coated with different matrix proteins, an inverse relationship
between Cx43 expression, GIJC and the migration rate was demon-
strated [50,51]. Similarly, when Boyden chambers without degra-
dation of matrix are used, an increased capacity of 3D migration
is associated with decreased Cx43 expression and GJIC in breast
cancer cells [52,53]. These data suggest that, when motility of indi-
vidual cells is tested, the migration capacity of tumor cells is inver-
sely correlated with GJIC and expression of Cx43.
The ﬁrst observation associating an ex vivo invasive 3D process
and connexin expression was made by using Hela cells transfected
with different connexin types (Cx32, Cx40 or Cx43). By doing so, it
was observed that these three connexins facilitated HeLa cells
invasion in embryonic chicken heart fragments which were cul-
tured in semi-solid agar. In those experiments, Cx43 expression
was correlated with the longer distance of invasion when com-
pared with HeLa cells expressing the two other types connexins
[54]. It seems that, in this type of ex vivo experiment, other
Cx43-dependent functions appeared. For example, heterocellular
GJIC between tumor cells and stromal cells seems to be essential
for activating tissue invasion. This has been demonstrated also
in vitro by using C6 rat glioma cells overexpressing Cx43. When
these cells are cocultured with astrocytes, they exhibit an in-
creased invasion capacity in Boyden chambers [38]. In such cocul-
tures permitting heterocellular GJIC with the stromal cells, the
Cx43-carboxy tail (Cx43-Ct) appears to be essential for the invasive
process involving matrix degradation. In such conditions, higher is
expressed Cx43 in C6 glioma cells and more the cells are invasive
in the 3D invasion test. Interestingly, this invasion capacity does
not decrease in the presence of a GJIC inhibitor but depends on
the presence of the Cx43-Ct [55,56]. Indeed, this particular func-
tion of the Cx43-Ct tail seems to be important for the formation
of the leading edge during cancer invasion [57]. Similarly, we have
shown that Cx43 controls the invasion capacity of U251 glioblas-
toma cells through its localization in lipid rafts. It appeared that
such a capacity could be mediated by the interaction between
Cx43-Ct and caveolin-1 (Cav-1; a lipid raft marker) [51]. Finally,
connexins could be involved in the invasion process through their
adhesion properties. Indeed, after transfection of Cx43 or Cx32
cDNAs in C6 glioma cells, an increase in cell aggregation capacity
is observed. This property might be carried by the extracellular
loops of connexins and not by their communication properties.
Collective cell migration chain is deﬁned as a migration process
used by carcinoma cells keeping their intercellular junctions. Such
a process could be mediated by the adhesion properties of connex-
ins. On the other side, the invasion process of C6 cells observed
in vivo shows that Cx43-positive cells have larger invasion capacity
inside the parenchyma than those transfected with Cx32. This
means that connexin adhesive property is not sufﬁcient to permit
invasion of surrounding tissue by tumor cells [58].
Regarding Cx26 and Cx32, it appears that these connexins have
an opposed effect on the behavior of tumor cells when compared to
Cx43. When Cx26 is up-regulated in breast cancer cells (MCF-7
cells), cell migration and invasion through matrigel in Boyden
chambers is reduced [59]. In another breast cancer cell line
(MDA-MB-435 cells), Cx26 alters the distribution of the actin cyto-
skeleton and reduces the 3D migration and invasion [25]. In 2007,
an experimental model was created for inducing the overexpres-
sion of a cytoplasmic and non-functional Cx32 in human hepato-
cellular carcinoma cells. From such a model, it appears that when
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is increased and consequently their metastasis behavior [60].
Therefore, it seems that the various possible functions of connexins
(GJIC, hemi-channel, or scaffolding protein function) may have dif-
ferent effects in cell migration or invasion processes. Moreover, a
recent study found that Cx31.1 may act on migration and invasion
of lung cancer cells. In such a study, the overexpression of Cx31.1
in the lung cancer cells (H1299 cells) eliminates their 3D migration
and invasion by inducing mesenchymal–epithelial transition
(MET) [61].
4.2. Cytoskeletal remodeling
During EMT, there is a remodeling of the cytoskeleton in which
cortical actin ﬁbers are redistributed in actin stress ﬁbers; a char-
acteristic of the mesenchymal phenotype. While the cytoskeleton
is remodeled, the accompanying disruption of intercellular adhe-
sions mechanically leads to loss of the apical-basolateral polarity
and involves Rho GTPases, Cdc42 and Rac. These three partners
play a major role in pro-migratory reorganization of actin ﬁla-
ments and formation of focal contacts with ECM in response to
activation of PI3K by extracellular chemotactic signals [62]. Rac
and Cdc42 were described to be responsible for polymerization
of actin microﬁlaments in periphery or cell anterior pole, by form-
ing membrane sheet structures (lamellipodia) or cell microspikes
(ﬁlopodia). Rac also induces formation of focal contacts with ECM
along these extensions. Moreover, Rho regulates, via ROCK/Rho ki-
nase, actin/myosin contraction and assembly of actin stress ﬁbers,
responsible for translating the cell body forward. Rho also may be
involved in the organization of actin ﬁbers for the invadopodia for-
mation which are cortactin dependent structures [63,64]. The pro-
metastatic role of the Rho family has been widely emphasized by
comparative genomic analysis techniques [65].
Above, we have seen that Cx43-Ct seems to play an important
role in the process of cancer cell invasion. This cytoplasmic Cx43
part interacts with many cytoskeleton proteins, including actin
[66]. In particular CCN3, a protein that binds to Cx43-Ct, is known
to be a direct activator of rac1 [67]. Thus, Cx43 could enhance the
migration/invasion process by activating small GTPases. What is
also interesting to consider is that Cx43 has been reported to inter-
act with cortactin, a protein associated with actin, to promote inva-
sive capacity by facilitating invadopodia formation [68,69]. In
addition, some authors showed that Cx43-Ct regulates motility
by interacting with proteins involved in lamellipodia formation
[70].5. Conclusion
During the embryonic development, EMT permits to epithelial
cells to exhibit a mesenchymal phenotype in response to different
types of stimuli. This transition results in a loss of intercellular
junctions (tight junctions, adherens junctions, desmosomes and
gap junctions), loss of apical-basolateral cell polarization marked
by selective localization of adhesion proteins (cadherins, integrins),
induction of protease expression, destruction of the basal mem-
brane and stroma invasion [71,72]. EMT is also known to be abnor-
mally reactivated in adults in at least two pathologies: tissue
ﬁbrosis and cancer. In cancer, EMT has been widely described to
be responsible for the metastatic potential acquisition by carci-
noma cells. And it has been reported in many models that tumor
progression in invasive and metastatic stages is associated with
cellular dedifferentiation, cell polarity alteration and acquisition
of ﬁbroblastoid morphology [73–75].
At ﬁrst glance, the involvement of connexins in this EMT pro-
cess appears to be contradictory. And this seems to be particularlythe case for Cx43 which has been extensively studied in this con-
text. However, when EMT is considered into different stages, some
coherence can be found in the various, and apparently contradic-
tory, roles that may be played by connexins during the invasive
process. Indeed, the ﬁrst step of EMT, which permits the detach-
ment of invasive cells from the primary tumor, is the loss of cad-
herin-dependent cell–cell adhesions and the establishment of
speciﬁc cell–matrix adhesion. The switch between E-cadherin
and N-cadherin which happens during this step is often accompa-
nied by a loss of junctional plaques associated with a loss of GJIC.
Contact with ECM via integrins appears to allow maintenance of
Cx43 expression associated with more or less organized junctional
plaques. At this point, the function of GJIC seems to establish het-
erocellular GJIC between tumor cells and stromal cells which, in
turn, activates the microenvironment; a crucial step for cancer cell
invasion. This activation of the peritumoral stroma allows secre-
tion and activation of stroma proteases which favor cell invasion
within the ECM. At this time, when the invasive process results
in reorganization of actin ﬁbers and membrane structures of the
tumor cell, the function of scaffold protein played by Cx43-Ct
and/or hemichannel may favor the invasive process mediated by
ECM-degradation. This assumption seems to be supported by the
fact that in plane migration process without cellular degradation
of the ECM, on a surface, Cx43 does not appear essential. However,
when EMT transforms a motionless cell in an invasive one, Cx43
seems to undergo different types of regulation at the transcrip-
tional, translational or post-translational levels that permit its
localization in triton insoluble structures of the plasma membrane
(lipid rafts). Furthermore, the involvement of Cx43 appears to be
mediated through its different functions such as GJIC, hemi-
channel and scaffold protein, depending on time and step of the
invasive process. What then are the signals controlling precisely
such a complex process?
The mechanisms regulating EMT are various: many extracellu-
lar activators may induce or inhibit this process, relayed by intra-
cellular signaling pathways (Wnt, Hedgehog, Notch and signaling
pathways activated by cytokines, TGF-b, EGF, FGF, HGF/SF) and
re-activation of transcription factors driving the process (proteins
Snail and Slug, Twist, Zeb and NF-kappaB) [72,76].
The association between the secretion of TGF-b and Cx43
expression has already been described in different models [77].
In the context of brain, it has been shown that TGF-b increases
astrocyte coupling while it decreases GJIC in the rat C6 glioma cells,
via a regulation of the Cx43 P2-phosphorylated form [78]. Another
example of EMT regulator has been linked to connexin. It seems
that there is a signaling HGF/c-Met/connexin involved in changing
liver architecture that increases the number of metastases at this
level [79,80]. Similarly, a recent study showed a correlation be-
tween the transcription factor Twist, associated with the formation
of metastasis [81–83] and expression of Cx43. Indeed, activation of
the TWIST gene in breast cancer cells causes increased expression
of Cx43 and GJIC associated with colonization of the brain [84].
Moreover, in melanoma cells, a possible link between different
markers important for EMT was shown. After activation of the
ET(B) receptor by treatment with ET-1 or ET-3, a decrease in the
expression of E-cadherin associated with an increase of N-cadherin
was observed. This involves a transcriptional mechanism since it
was seen an increased expression of snail mRNA, associated with
an inhibition of GIJC by Cx43 phosphorylation. This was accompa-
nied by an increased expression of integrins (ayb3 and a2b1),
MMP-2 and -9 activation of MT-MMP-1 and secretion of TIMP2.
These phenomena seem to go through the activation of signaling
proteins involving FAK and ERK1/2 [33,85].
In conclusion, connexins, and particularly Cx43, tend to play a
pivotal role in the control of cell migration and invasion. This role
seems to be the consequence of an accumulation of functions that
N. Defamie et al. / FEBS Letters 588 (2014) 1331–1338 1337Cx43 may carry out simultaneously or in different times during the
acquisition of the invasive process and its maintenance. Such an
accumulation of functions is favored by the possibility that Cx43
acts intracellularly by interacting with various cytosolic proteins
involved in the regulation of the migration machinery and secre-
tion of proteases. But it is also favored by the capacity of Cx43 to
mediate hemichannel transmembrane communication with the
microenvironment or heterocellular GJIC with stromal cells.
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